ENGN
enGene Holdings Inc

935
Loading...
Loading...
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
57

Frequently Asked Questions

What is Market Cap of enGene Holdings Inc?
What is the 52-week high for enGene Holdings Inc?
What is the 52-week low for enGene Holdings Inc?
What is enGene Holdings Inc stock price today?
What was enGene Holdings Inc stock price yesterday?
What is the PE ratio of enGene Holdings Inc?
What is the Price-to-Book ratio of enGene Holdings Inc?
What is the 50-day moving average of enGene Holdings Inc?
How many employess does enGene Holdings Inc has?

Latest ENGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.